Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
Sponsor: Novartis Pharmaceuticals
Summary
This study was planned as a prospective multicenter NIS. This study was observational in nature and did not impose a therapy protocol, diagnostic/therapeutic interventions or a visit schedule. Patients with HR+/ HER2- advanced or metastatic BC that initiated treatment with ribociclib, alpelisib, mono endocrine therapy or chemotherapy were included in the study across seven Russian districts.
Official title: A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg® (Ribociclib), Piqray® (Alpelisib), Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
Key Details
Gender
FEMALE
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
2390
Start Date
2021-07-27
Completion Date
2025-07-28
Last Updated
2026-08-13
Healthy Volunteers
No
Conditions
Interventions
ribociclib
There was no treatment allocation. Patients administered ribociclib by prescription that had started before inclusion of the patient into the study were enrolled.
aplelicib
There was no treatment allocation. Patients administered aplelicib by prescription that had started before inclusion of the patient into the study were enrolled.
mono endocrine therapy
There was no treatment allocation. Patients administered mono endocrine therapy by prescription that had started before inclusion of the patient into the study were enrolled.
chemotherapy
There was no treatment allocation. Patients administered chemotherapy by prescription that had started before inclusion of the patient into the study were enrolled.
Locations (58)
Novartis Investigative Site
Syktyvkar, Komi, Russia
Novartis Investigative Site
Sochi, Russian Federation, Russia
Novartis Investigative Site
Kaluga, Russia, Russia
Novartis Investigative Site
Surgut, Tymen Area, Russia
Novartis Investigative Site
Arkhangelsk, Russia
Novartis Investigative Site
Barnaul, Russia
Novartis Investigative Site
Belgorod, Russia
Novartis Investigative Site
Bryansk, Russia
Novartis Investigative Site
Cheboksary, Russia
Novartis Investigative Site
Chelyabinsk, Russia
Novartis Investigative Site
Cherkessk, Russia
Novartis Investigative Site
Chita, Russia
Novartis Investigative Site
Irkutsk, Russia
Novartis Investigative Site
Ivanovo, Russia
Novartis Investigative Site
Izhevsk, Russia
Novartis Investigative Site
Kaliningrad, Russia
Novartis Investigative Site
Khabarovsk, Russia
Novartis Investigative Site
Khanty-Mansiysk, Russia
Novartis Investigative Site
Kirov, Russia
Novartis Investigative Site
Kostroma, Russia
Novartis Investigative Site
Krasnodar, Russia
Novartis Investigative Site
Krasnoyarsk, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Moscow Region Balas, Russia
Novartis Investigative Site
Nal'chik, Russia
Novartis Investigative Site
Nizhny Novgorod, Russia
Novartis Investigative Site
Novosibirsk, Russia
Novartis Investigative Site
Odintsovo, Russia
Novartis Investigative Site
Omsk, Russia
Novartis Investigative Site
Perm, Russia
Novartis Investigative Site
Podolsk, Russia
Novartis Investigative Site
Pyatigorsk, Russia
Novartis Investigative Site
Rostov-on-Don, Russia
Novartis Investigative Site
Saint Petersburg, Russia
Novartis Investigative Site
Saint Petersburg, Russia
Novartis Investigative Site
Saint Petersburg, Russia
Novartis Investigative Site
Saransk, Russia
Novartis Investigative Site
Saratov, Russia
Novartis Investigative Site
Sestroretsk, Russia
Novartis Investigative Site
Sevastopol’, Russia
Novartis Investigative Site
Severodvinsk, Russia
Novartis Investigative Site
Simferopol, Russia
Novartis Investigative Site
Tambov, Russia
Novartis Investigative Site
Tula, Russia
Novartis Investigative Site
Tver', Russia
Novartis Investigative Site
Tyumen, Russia
Novartis Investigative Site
Ufa, Russia
Novartis Investigative Site
Vladikavkaz, Russia
Novartis Investigative Site
Vladivostok, Russia
Novartis Investigative Site
Voronezh, Russia
Novartis Investigative Site
Yekaterinburg, Russia
Novartis Investigative Site
Yekaterinburg, Russia
Novartis Investigative Site
Yuzhno-Sakhalinsk, Russia